Opportunity Information: Apply for PAR 15 275
Apply for PAR 15 275
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Ethical Issues in Research on HIV/AIDS and its Co Morbidities (R21)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242 Mental Health Research Grants 93.393 Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research 93.395 Cancer Treatment Research 93.396 Cancer Biology Research 93.399 Cancer Control 93.855 Allergy and Infectious Diseases Research 93.856 Microbiology and Infectious Diseases Research.
- This funding opportunity was created on Jun 9, 2015 and posted on Jun 9, 2015.
- Applicants must submit their applications by Jan 8, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: For profit organizations other than small businesses County governments Private institutions of higher education State governments Special district governments Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Native American tribal governments (Federally recognized) Others (see text field entitled Additional Information on Eligibility for clarification) Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NIH funding opportunity PAR-15-275, titled "Ethical Issues in Research on HIV/AIDS and its Co-Morbidities (R21)," is a discretionary grant program that supports exploratory and developmental research focused on the ethical challenges that arise in the context of HIV-related research. The core purpose is to encourage studies that examine, clarify, and propose solutions to ethical questions linked to conducting research on HIV and HIV-associated co-morbidities, especially when the work involves people living with HIV or populations at elevated risk of acquiring HIV. In practical terms, this FOA is aimed at strengthening the ethical foundation of HIV research by funding projects that can generate new insights, conceptual frameworks, or preliminary evidence that can later be expanded into larger lines of inquiry.
This FOA uses the NIH R21 mechanism, which is commonly used to fund early-stage, high-impact, or innovative projects where the goal is to break new ground rather than to run a large, fully mature research program. The maximum award amount listed is $200,000 (award ceiling), and there is no cost sharing or matching requirement, meaning applicants are not required to contribute their own funds as a condition of receiving the award. The opportunity was posted on June 9, 2015, with an original and final closing date of January 8, 2018, and it was archived on February 8, 2018, indicating that it is no longer accepting applications under that specific announcement as written.
The subject matter focus is ethics in HIV research broadly defined, with explicit attention to co-morbidities, which can include other infectious diseases, cancers, mental health conditions, substance use disorders, and additional health issues that commonly intersect with HIV. The ethical dimensions in such research can involve questions about informed consent in complex clinical and social settings, privacy and confidentiality in studies where HIV status and related conditions carry stigma, fair participant selection and equitable access to research benefits, risk-benefit assessment in prevention and treatment trials, the ethics of involving highly vulnerable or marginalized communities, and obligations researchers may have related to ancillary care, linkage to services, or disclosure of clinically relevant findings. Because the announcement explicitly mentions populations living with HIV and those at high risk of HIV acquisition, the intent clearly includes ethics questions that come up in prevention research as well as treatment and co-morbidity research, including situations where social, legal, or economic factors shape participant vulnerability.
Eligibility under this FOA is broad and includes many types of domestic and international entities. Eligible applicants include for-profit organizations (including those other than small businesses), small businesses, nonprofit organizations (both with and without 501(c)(3) status), public and private institutions of higher education, and a wide range of government entities such as state governments, county governments, cities or townships, special district governments, independent school districts, and public housing authorities or Indian housing authorities. The FOA also highlights eligibility for tribal governments and organizations, including federally recognized Native American tribal governments and other tribal organizations, along with tribally controlled colleges and universities. In addition, it explicitly includes a range of mission-serving and community-anchored institutions such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Alaska Native and Native Hawaiian-serving Institutions, Asian American Native American Pacific Islander-serving Institutions (AANAPISIs), and faith-based or community-based organizations. It also allows non-U.S. entities (foreign organizations), regional organizations, and U.S. territories or possessions, reflecting NIH interest in ethical issues that may be especially salient in international and cross-cultural HIV research settings.
From an administrative standpoint, the opportunity is associated with multiple CFDA numbers spanning mental health research and a broad set of cancer and infectious disease research categories, including allergy and infectious diseases and microbiology and infectious diseases. That breadth reflects how HIV ethics questions frequently overlap with mental health, oncology, infectious disease co-infections, and other areas where co-morbidities and complex care needs raise distinct ethical concerns. The sponsoring agency is the National Institutes of Health, and the full announcement was made available through the NIH grants guide page linked in the source data.
For applicants or readers trying to understand what NIH was looking to stimulate through this R21, the takeaway is that the FOA was designed to fund focused, innovative projects that directly tackle ethical problems in HIV research practice and policy. The projects supported under a mechanism like this would typically be expected to produce practical and scholarly outputs such as ethical analyses, empirically informed guidance, recommendations for research oversight, conceptual models, or pilot data that could inform future larger studies. The listed contact support in the source data points to the NIH Office of Extramural Research (OER) webmaster addresses for technical access and linking issues related to the announcement.
FAQs: NIH PAR-15-275 - Ethical Issues in Research on HIV/AIDS and its Co-Morbidities (R21)
What is PAR-15-275?
PAR-15-275 is an NIH funding opportunity announcement titled "Ethical Issues in Research on HIV/AIDS and its Co-Morbidities (R21)." It is a discretionary grant program intended to support exploratory and developmental research that focuses on ethical challenges arising in HIV-related research.
What is the main purpose of this funding opportunity?
The purpose is to encourage studies that examine, clarify, and propose solutions to ethical questions connected to conducting research on HIV and HIV-associated co-morbidities, particularly when research involves people living with HIV or populations at elevated risk of acquiring HIV. The broader goal is to strengthen the ethical foundation of HIV research by supporting projects that generate new insights, frameworks, or preliminary evidence that can later grow into larger research efforts.
What grant mechanism does this opportunity use?
This opportunity uses the NIH R21 mechanism, which is commonly used to fund early-stage, innovative, or high-impact projects designed to break new ground rather than support a large, fully mature research program.
What is the maximum award amount?
The listed award ceiling is $200,000.
Is cost sharing or matching required?
No. There is no cost sharing or matching requirement, meaning applicants are not required to contribute their own funds as a condition of receiving the award.
Is this funding opportunity still accepting applications?
No. The opportunity was archived on February 8, 2018, and the original and final closing date was January 8, 2018. As written in that specific announcement, it is no longer accepting applications.
When was the opportunity posted?
The opportunity was posted on June 9, 2015.
What is the scientific and policy focus of the announcement?
The focus is ethics in HIV research broadly defined, with explicit attention to HIV-associated co-morbidities and the ethical questions that arise in research settings involving HIV and related conditions.
What does "co-morbidities" include in the context of this FOA?
The announcement highlights co-morbidities that can intersect with HIV, including other infectious diseases, cancers, mental health conditions, substance use disorders, and other health issues commonly seen alongside HIV.
What kinds of ethical issues are relevant under this FOA?
Ethical dimensions described in the opportunity include issues such as informed consent in complex clinical and social contexts, privacy and confidentiality where HIV status or related conditions may be stigmatized, fair participant selection and equitable access to research benefits, risk-benefit assessment in prevention and treatment trials, ethics of involving highly vulnerable or marginalized communities, and potential researcher obligations related to ancillary care, linkage to services, or disclosure of clinically relevant findings.
Does the FOA include prevention research, treatment research, or both?
Both. Because the announcement explicitly mentions people living with HIV and populations at high risk of HIV acquisition, it clearly includes ethical questions that arise in prevention research as well as treatment and co-morbidity research.
Why does the announcement emphasize populations at elevated risk of acquiring HIV?
The emphasis signals that NIH was interested in ethics questions that arise when conducting research with communities that may face heightened vulnerability due to social, legal, or economic factors, including in prevention contexts.
What types of outputs would an R21 project under this FOA typically aim to produce?
Projects supported under this type of mechanism would typically be expected to produce practical and scholarly outputs such as ethical analyses, empirically informed guidance, recommendations for research oversight, conceptual models, or pilot data that can inform future, larger studies.
Who is eligible to apply?
Eligibility is broad and includes many domestic and international entities, including for-profit organizations (including those other than small businesses), small businesses, nonprofit organizations (with or without 501(c)(3) status), public and private institutions of higher education, and a wide range of government entities.
Are government entities eligible, and which ones are listed?
Yes. Eligible government applicants include state governments, county governments, cities or townships, special district governments, independent school districts, and public housing authorities or Indian housing authorities.
Are tribal governments and tribal organizations eligible?
Yes. The FOA highlights eligibility for federally recognized Native American tribal governments and other tribal organizations, including tribally controlled colleges and universities.
Are community-anchored or mission-serving institutions eligible?
Yes. The FOA explicitly includes a range of mission-serving and community-anchored institutions such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Alaska Native and Native Hawaiian-serving Institutions, Asian American Native American Pacific Islander-serving Institutions (AANAPISIs), and faith-based or community-based organizations.
Are non-U.S. (foreign) organizations eligible to apply?
Yes. The announcement allows non-U.S. entities (foreign organizations), regional organizations, and U.S. territories or possessions.
Why does the FOA include international and cross-cultural research settings?
The eligibility language reflects NIH interest in ethical issues that may be especially important in international and cross-cultural HIV research settings.
Which agency sponsors this opportunity?
The sponsoring agency is the National Institutes of Health (NIH).
What do the CFDA numbers indicate for this opportunity?
The opportunity is associated with multiple CFDA numbers spanning mental health research and a broad set of cancer and infectious disease research categories, including allergy and infectious diseases and microbiology and infectious diseases. This breadth reflects how HIV ethics questions often overlap with mental health, oncology, and infectious disease co-infections, as well as other complex care contexts.
Where was the full announcement made available?
The full announcement was made available through an NIH grants guide page linked in the source data.
Who is listed as a contact for technical or access issues?
The listed contact support points to NIH Office of Extramural Research (OER) webmaster addresses for technical access and linking issues related to the announcement.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: National Park Service Restoration Monitoring for Lulu City Wetland
Previous opportunity: Ethical Issues in Research on HIV/AIDS and its Co Morbidities (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 15 275
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 15 275) also looked into and applied for these:
| Funding Opportunity |
|---|
| Turkey US Collaborative Program for Affordable Medical Technologies (R01) Apply for PAR 15 276 Funding Number: PAR 15 276 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Multidisciplinary Studies of HIV/AIDS and Aging (R01) Apply for PAR 15 280 Funding Number: PAR 15 280 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Multidisciplinary Studies of HIV/AIDS and Aging (R03) Apply for PAR 15 281 Funding Number: PAR 15 281 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Multidisciplinary Studies of HIV/AIDS and Aging (R21) Apply for PAR 15 282 Funding Number: PAR 15 282 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Extracellular Vesicles and Substance Abuse (R21) Apply for PAR 15 284 Funding Number: PAR 15 284 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Extracellular Vesicles and Substance Abuse (R01) Apply for PAR 15 283 Funding Number: PAR 15 283 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| The Pancreatic Cancer Detection Consortium (U01) Apply for PAR 15 289 Funding Number: PAR 15 289 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01) Apply for PAR 15 297 Funding Number: PAR 15 297 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Tools for Monitoring and Manipulating Modified RNAs in the Nervous System (R43/R44) Apply for RFA DA 16 005 Funding Number: RFA DA 16 005 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Tools for Monitoring and Manipulating Modified RNAs in the Nervous System (R41/R42) Apply for RFA DA 16 006 Funding Number: RFA DA 16 006 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Supplements to Support Evaluation of the NCI Cancer Genomics Cloud Pilots (Admin Supp) Apply for PA 15 305 Funding Number: PA 15 305 Agency: National Institutes of Health Category: Education Health Funding Amount: $40,000 |
| Physical Activity and Weight Control Interventions Among Cancer Survivors Effects on Biomarkers of Prognosis and Survival (R01) Apply for PA 15 311 Funding Number: PA 15 311 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Physical Activity and Weight Control Interventions Among Cancer Survivors Effects on Biomarkers of Prognosis and Survival (R21) Apply for PA 15 310 Funding Number: PA 15 310 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Imaging Science Track Award for Research Transition (I/START) (R03) Apply for PAR 15 326 Funding Number: PAR 15 326 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Avenir Award Program for Genetics or Epigenetics of Substance Abuse (DP1) Apply for RFA DA 16 007 Funding Number: RFA DA 16 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Early Stage Development of Informatics Technologies for Cancer Research and Management (U01) Apply for PAR 15 332 Funding Number: PAR 15 332 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Advanced Development of Informatics Technologies for Cancer Research and Management (U24) Apply for PAR 15 331 Funding Number: PAR 15 331 Agency: National Institutes of Health Category: Education Health Funding Amount: $600,000 |
| Sustained Support for Informatics Resources for Cancer Research and Management (U24) Apply for PAR 15 333 Funding Number: PAR 15 333 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21) Apply for PAR 15 334 Funding Number: PAR 15 334 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Exploratory Multi site Palliative Care Research in Diverse Populations Utilizing the Palliative Care Research Cooperative (PCRC) Group (R21) Apply for PAR 15 337 Funding Number: PAR 15 337 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 15 275", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
